1 Study Coverage
1.1 Human Erythropoietin Revenue in Human Erythropoietin Business (2021-2025) & (US$ Million) Introduction
1.2 Global Human Erythropoietin Outlook 2021 VS 2025 VS 2031
1.2.1 Global Human Erythropoietin Market Size for the Year 2025-2031
1.2.2 Global Human Erythropoietin Market Size for the Year 2025-2031
1.3 Human Erythropoietin Market Size, United States VS Global, 2021 VS 2025 VS 2031
1.3.1 The Market Share of United States Human Erythropoietin in Global, 2021 VS 2025 VS 2031
1.3.2 The Growth Rate of Human Erythropoietin Market Size, United States VS Global, 2021 VS 2025 VS 2031
1.4 Human Erythropoietin Market Dynamics
1.4.1 Human Erythropoietin Industry Trends
1.4.2 Human Erythropoietin Market Drivers
1.4.3 Human Erythropoietin Market Challenges
1.4.4 Human Erythropoietin Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Human Erythropoietin by Type
2.1 Human Erythropoietin Market Segment by Type
2.1.1 Epoetin-alfa
2.1.2 Epoetin-beta
2.1.3 Darbepoetin-alfa
2.1.4 Others
2.2 Global Human Erythropoietin Market Size by Type (2021, 2025 & 2031)
2.3 Global Human Erythropoietin Market Size by Type (2025-2031)
2.4 United States Human Erythropoietin Market Size by Type (2021, 2025 & 2031)
2.5 United States Human Erythropoietin Market Size by Type (2025-2031)
3 Human Erythropoietin by Application
3.1 Human Erythropoietin Market Segment by Application
3.1.1 Anemia
3.1.2 Kidney Disorders
3.1.3 Others
3.2 Global Human Erythropoietin Market Size by Application (2021, 2025 & 2031)
3.3 Global Human Erythropoietin Market Size by Application (2025-2031)
3.4 United States Human Erythropoietin Market Size by Application (2021, 2025 & 2031)
3.5 United States Human Erythropoietin Market Size by Application (2025-2031)
4 Global Human Erythropoietin Competitor Landscape by Company
4.1 Global Human Erythropoietin Market Size by Company
4.1.1 Top Global Human Erythropoietin Companies Ranked by Revenue (2025)
4.1.2 Global Human Erythropoietin Revenue by Player (2021-2025)
4.2 Global Human Erythropoietin Concentration Ratio (CR)
4.2.1 Human Erythropoietin Market Concentration Ratio (CR) (2021-2025)
4.2.2 Global Top 5 and Top 10 Largest Companies of Human Erythropoietin in 2021
4.2.3 Global Human Erythropoietin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Human Erythropoietin Headquarters, Revenue in Human Erythropoietin Business (2021-2025) & (US$ Million) Type
4.3.1 Global Human Erythropoietin Headquarters and Area Served
4.3.2 Global Human Erythropoietin Companies Revenue in Human Erythropoietin Business (2021-2025) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Human Erythropoietin Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Human Erythropoietin Market Size by Company
4.5.1 Top Human Erythropoietin Players in United States, Ranked by Revenue (2025)
4.5.2 United States Human Erythropoietin Revenue by Players (2023, 2024 & 2025)
5 Global Human Erythropoietin Market Size by Region
5.1 Global Human Erythropoietin Market Size by Region: 2021 VS 2025 VS 2031
5.2 Global Human Erythropoietin Market Size by Region (2025-2031)
5.2.1 Global Human Erythropoietin Market Size by Region: 2021-2025
5.2.2 Global Human Erythropoietin Market Size by Region (2025-2031)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Human Erythropoietin Market Size YoY Growth 2025-2031
6.1.2 North America Human Erythropoietin Market Facts & Figures by Country (2021, 2025 & 2031)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Human Erythropoietin Market Size YoY Growth 2025-2031
6.2.2 Asia-Pacific Human Erythropoietin Market Facts & Figures by Region (2021, 2025 & 2031)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Human Erythropoietin Market Size YoY Growth 2025-2031
6.3.2 Europe Human Erythropoietin Market Facts & Figures by Country (2021, 2025 & 2031)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Human Erythropoietin Market Size YoY Growth 2025-2031
6.4.2 Latin America Human Erythropoietin Market Facts & Figures by Country (2021, 2025 & 2031)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Human Erythropoietin Market Size YoY Growth 2025-2031
6.5.2 Middle East and Africa Human Erythropoietin Market Facts & Figures by Country (2021, 2025 & 2031)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Amgen
7.1.1 Amgen Company Details
7.1.2 Amgen Business Overview
7.1.3 Amgen Human Erythropoietin Introduction
7.1.4 Amgen Revenue in Human Erythropoietin Business (2021-2025)
7.1.5 Amgen Recent Development
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Details
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Human Erythropoietin Introduction
7.2.4 Johnson & Johnson Revenue in Human Erythropoietin Business (2021-2025)
7.2.5 Johnson & Johnson Recent Development
7.3 Roche
7.3.1 Roche Company Details
7.3.2 Roche Business Overview
7.3.3 Roche Human Erythropoietin Introduction
7.3.4 Roche Revenue in Human Erythropoietin Business (2021-2025)
7.3.5 Roche Recent Development
7.4 Galenica
7.4.1 Galenica Company Details
7.4.2 Galenica Business Overview
7.4.3 Galenica Human Erythropoietin Introduction
7.4.4 Galenica Revenue in Human Erythropoietin Business (2021-2025)
7.4.5 Galenica Recent Development
7.5 Emcure
7.5.1 Emcure Company Details
7.5.2 Emcure Business Overview
7.5.3 Emcure Human Erythropoietin Introduction
7.5.4 Emcure Revenue in Human Erythropoietin Business (2021-2025)
7.5.5 Emcure Recent Development
7.6 Kyowa Hakko Kirin
7.6.1 Kyowa Hakko Kirin Company Details
7.6.2 Kyowa Hakko Kirin Business Overview
7.6.3 Kyowa Hakko Kirin Human Erythropoietin Introduction
7.6.4 Kyowa Hakko Kirin Revenue in Human Erythropoietin Business (2021-2025)
7.6.5 Kyowa Hakko Kirin Recent Development
7.7 3SBio
7.7.1 3SBio Company Details
7.7.2 3SBio Business Overview
7.7.3 3SBio Human Erythropoietin Introduction
7.7.4 3SBio Revenue in Human Erythropoietin Business (2021-2025)
7.7.5 3SBio Recent Development
7.8 Biocon
7.8.1 Biocon Company Details
7.8.2 Biocon Business Overview
7.8.3 Biocon Human Erythropoietin Introduction
7.8.4 Biocon Revenue in Human Erythropoietin Business (2021-2025)
7.8.5 Biocon Recent Development
7.9 LG Life Sciences
7.9.1 LG Life Sciences Company Details
7.9.2 LG Life Sciences Business Overview
7.9.3 LG Life Sciences Human Erythropoietin Introduction
7.9.4 LG Life Sciences Revenue in Human Erythropoietin Business (2021-2025)
7.9.5 LG Life Sciences Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

List of Tables
Table 1. Human Erythropoietin Market Size United States VS Global, CAGR (2021 VS 2025 VS 2031)
Table 2. Human Erythropoietin Market Trends
Table 3. Human Erythropoietin Market Drivers
Table 4. Human Erythropoietin Market Challenges
Table 5. Human Erythropoietin Market Restraints
Table 6. Global Human Erythropoietin Market Size by Type: 2021 VS 2025 VS 2031 (US$ Million)
Table 7. United States Human Erythropoietin Market Size by Type: 2021 VS 2025 VS 2031 (US$ Million)
Table 8. Global Human Erythropoietin Market Size by Application: 2021 VS 2025 VS 2031 (US$ Million)
Table 9. United States Human Erythropoietin Market Size by Application: 2021 VS 2025 VS 2031 (US$ Million)
Table 10. Top Human Erythropoietin Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Human Erythropoietin Revenue by Player, (US$ Million), 2021-2025
Table 12. Global Human Erythropoietin Revenue Share by Player, 2021-2025
Table 13. Global Human Erythropoietin Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Erythropoietin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Erythropoietin as of 2021)
Table 15. Top Players of Human Erythropoietin in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Human Erythropoietin Business (2021-2025) & (US$ Million) Type
Table 17. Date of International Companies Enter into Human Erythropoietin Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Human Erythropoietin Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Human Erythropoietin Revenue by Players, (US$ Million), 2023, 2024 & 2025
Table 21. United States Human Erythropoietin Revenue Share by Players, 2023, 2024 & 2025
Table 22. Global Human Erythropoietin Market Size by Region (US$ Million): 2021 VS 2025 VS 2031
Table 23. Global Human Erythropoietin Market Size by Region (2021-2025) & (US$ Million)
Table 24. Global Human Erythropoietin Market Size Forecast by Region (2025-2031) & (US$ Million)
Table 25. North America Human Erythropoietin Sales in Value by Country (2025-2031) & (US$ Million)
Table 26. Asia Pacific Human Erythropoietin Sales in Value by Region (2025-2031) & (US$ Million)
Table 27. Europe Human Erythropoietin Sales in Value by Country (2025-2031) & (US$ Million)
Table 28. Latin Americaa Human Erythropoietin Sales in Value by Country (2025-2031) & (US$ Million)
Table 29. Middle East and Africa Human Erythropoietin Sales in Value by Country (2025-2031) & (US$ Million)
Table 30. Amgen Company Details
Table 31. Amgen Business Overview
Table 32. Amgen Human Erythropoietin Product
Table 33. Amgen Revenue in Human Erythropoietin Business (2021-2025) & (US$ Million)
Table 34. Amgen Recent Development
Table 35. Johnson & Johnson Company Details
Table 36. Johnson & Johnson Business Overview
Table 37. Johnson & Johnson Human Erythropoietin Product
Table 38. Johnson & Johnson Revenue in Human Erythropoietin Business (2021-2025) & (US$ Million)
Table 39. Johnson & Johnson Recent Development
Table 40. Roche Company Details
Table 41. Roche Business Overview
Table 42. Roche Human Erythropoietin Product
Table 43. Roche Revenue in Human Erythropoietin Business (2021-2025) & (US$ Million)
Table 44. Roche Recent Development
Table 45. Galenica Company Details
Table 46. Galenica Business Overview
Table 47. Galenica Human Erythropoietin Product
Table 48. Galenica Revenue in Human Erythropoietin Business (2021-2025) & (US$ Million)
Table 49. Galenica Recent Development
Table 50. Emcure Company Details
Table 51. Emcure Business Overview
Table 52. Emcure Human Erythropoietin Product
Table 53. Emcure Revenue in Human Erythropoietin Business (2021-2025) & (US$ Million)
Table 54. Emcure Recent Development
Table 55. Kyowa Hakko Kirin Company Details
Table 56. Kyowa Hakko Kirin Business Overview
Table 57. Kyowa Hakko Kirin Human Erythropoietin Product
Table 58. Kyowa Hakko Kirin Revenue in Human Erythropoietin Business (2021-2025) & (US$ Million)
Table 59. Kyowa Hakko Kirin Recent Development
Table 60. 3SBio Company Details
Table 61. 3SBio Business Overview
Table 62. 3SBio Human Erythropoietin Product
Table 63. 3SBio Revenue in Human Erythropoietin Business (2021-2025) & (US$ Million)
Table 64. 3SBio Recent Development
Table 65. Biocon Company Details
Table 66. Biocon Business Overview
Table 67. Biocon Human Erythropoietin Product
Table 68. Biocon Revenue in Human Erythropoietin Business (2021-2025) & (US$ Million)
Table 69. Biocon Recent Development
Table 70. LG Life Sciences Company Details
Table 71. LG Life Sciences Business Overview
Table 72. LG Life Sciences Human Erythropoietin Product
Table 73. LG Life Sciences Revenue in Human Erythropoietin Business (2021-2025) & (US$ Million)
Table 74. LG Life Sciences Recent Development
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Erythropoietin Product Picture
Figure 2. Global Human Erythropoietin Market Size, (US$ Million), 2021 VS 2025 VS 2031
Figure 3. Global Human Erythropoietin Market Size 2025-2031 (US$ Million)
Figure 4. United States Human Erythropoietin Market Size, (US$ Million), 2021 VS 2025 VS 2031
Figure 5. United States Human Erythropoietin Market Size 2025-2031 (US$ Million)
Figure 6. United States Human Erythropoietin Market Share in Global 2025-2031
Figure 7. Human Erythropoietin Report Years Considered
Figure 8. Product Picture of Epoetin-alfa
Figure 9. Product Picture of Epoetin-beta
Figure 10. Product Picture of Darbepoetin-alfa
Figure 11. Product Picture of Others
Figure 12. Global Human Erythropoietin Market Share by Type in 2025 & 2031
Figure 13. Global Human Erythropoietin Market Size by Type (2025-2031) & (US$ Million)
Figure 14. Global Human Erythropoietin Market Share by Type (2025-2031)
Figure 15. United States Human Erythropoietin Market Share by Type in 2025 & 2031
Figure 16. United States Human Erythropoietin Market Size by Type (2025-2031) & (US$ Million)
Figure 17. United States Human Erythropoietin Market Share by Type (2025-2031)
Figure 18. Product Picture of Anemia
Figure 19. Product Picture of Kidney Disorders
Figure 20. Product Picture of Others
Figure 21. Global Human Erythropoietin Market Share by Application in 2025 & 2031
Figure 22. Global Human Erythropoietin Market Size by Application (2025-2031) & (US$ Million)
Figure 23. Global Human Erythropoietin Market Share by Application (2025-2031)
Figure 24. United States Human Erythropoietin Market Share by Application in 2025 & 2031
Figure 25. United States Human Erythropoietin Market Size by Application (2025-2031) & (US$ Million)
Figure 26. United States Human Erythropoietin Market Share by Application (2025-2031)
Figure 27. North America Human Erythropoietin Market Size Growth Rate 2025-2031 (US$ Million)
Figure 28. United States Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 29. Canada Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 30. Europe Human Erythropoietin Market Size Growth Rate 2025-2031 (US$ Million)
Figure 31. Germany Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 32. France Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 33. U.K. Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 34. Italy Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 35. Russia Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 36. Asia-Pacific Human Erythropoietin Market Size Growth Rate 2025-2031 (US$ Million)
Figure 37. China Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 38. Japan Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 39. South Korea Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 40. India Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 41. Australia Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 42. China Taiwan Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 43. Indonesia Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 44. Thailand Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 45. Malaysia Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 46. Latin America Human Erythropoietin Market Size Growth Rate 2025-2031 (US$ Million)
Figure 47. Mexico Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 48. Brazil Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 49. Argentina Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 50. Middle East & Africa Human Erythropoietin Market Size Growth Rate 2025-2031 (US$ Million)
Figure 51. Turkey Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 52. Saudi Arabia Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 53. UAE Human Erythropoietin Market Size Growth Rate (2025-2031) & (US$ Million)
Figure 54. Amgen Revenue Growth Rate in Human Erythropoietin Business (2021-2025)
Figure 55. Johnson & Johnson Revenue Growth Rate in Human Erythropoietin Business (2021-2025)
Figure 56. Roche Revenue Growth Rate in Human Erythropoietin Business (2021-2025)
Figure 57. Galenica Revenue Growth Rate in Human Erythropoietin Business (2021-2025)
Figure 58. Emcure Revenue Growth Rate in Human Erythropoietin Business (2021-2025)
Figure 59. Kyowa Hakko Kirin Revenue Growth Rate in Human Erythropoietin Business (2021-2025)
Figure 60. 3SBio Revenue Growth Rate in Human Erythropoietin Business (2021-2025)
Figure 61. Biocon Revenue Growth Rate in Human Erythropoietin Business (2021-2025)
Figure 62. LG Life Sciences Revenue Growth Rate in Human Erythropoietin Business (2021-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

The research methodology employed by VICResearch has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of VICResearch. VICResearch’s methodology can be divided into five stages:

Stage 1: Secondary research
The research team first works with magazines, industry trade group, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.

Stage 2: Primary research: interviews with trade sources
After the first stage, the research team conducts large number of face-to-face or telephone interviews with the representative companies operating in the research field. The analysts attempt to obtain a chance to talk with leading players in the field as well as with small companies. The upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers are all included in the interviews. The data gathered during the interview is then carefully checked and compared with the secondary research.

Stage 3: Analysis of the gathered data
The analysis team checks and synthesizes the data gathered during the first two stages. To validate the data, a second series of interviews can be conducted.

Stage 4: Quantitative data
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by VICResearch. The data is based on the estimates obtained during stage 3.
The research team also provides appreciation and analysis of the market and the quantitative data contained in the reports. The data is consequently unique to VICResearch.

Stage 5: Quality control
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the VICResearch’s internal quality process.